Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs. Sitagliptin in Ketosis-Prone Diabetes
NCT01099618Phase 4Completed
- Start
- Mar 2010
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs), sitagliptin in Ketosis-prone diabetes mellitus (KPD). Started Mar 2010; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)sitagliptin
03
Conditions
Ketosis-prone diabetes mellitus (KPD)
Beyond the preview
Go deeper on NCT01099618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01099618.